Abstract
B cell receptor (BCR)-mediated antigen recognition is thought to regulate B cell differentiation. BCR signal strength may also influence B cell fate decisions. Here, we used the Epstein-Barr virus protein LMP2A as a constitutively active BCR surrogate to study the contribution of BCR signal strength in B cell differentiation. Mice carrying a targeted replacement of Igh by LMP2A leading to high or low expression of the LMP2A protein developed B-1 or follicular and marginal zone B cells, respectively. These data indicate that BCR signal strength, rather than antigen specificity, determines mature B cell fate. Furthermore, spontaneous germinal centers developed in gut-associated lymphoid tissue of LMP2A mice, indicating that microbial antigens can promote germinal centers independently of BCR-mediated antigen recognition.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Berland, R. & Wortis, H.H. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20, 253–300 (2002).
Rajewsky, K. Clonal selection and learning in the antibody system. Nature 381, 751–758 (1996).
Martin, F. & Kearney, J.F. Marginal-zone B cells. Nat. Rev. Immunol. 2, 323–335 (2002).
Hao, Z. & Rajewsky, K. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J. Exp. Med. 194, 1151–1164 (2001).
Schamel, W.W. & Reth, M. Monomeric and oligomeric complexes of the B cell antigen receptor. Immunity 13, 5–14 (2000).
Lalor, P.A. & Morahan, G. The peritoneal Ly-1 (CD5) B cell repertoire is unique among murine B cell repertoires. Eur. J. Immunol. 20, 485–492 (1990).
Hayakawa, K. et al. Positive selection of natural autoreactive B cells. Science 285, 113–116 (1999).
Cariappa, A. & Pillai, S. Antigen-dependent B-cell development. Curr. Opin. Immunol. 14, 241–249 (2002).
Bannish, G., Fuentes-Panana, E.M., Cambier, J.C., Pear, W.S. & Monroe, J.G. Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis. J. Exp. Med. 194, 1583–1596 (2001).
Chen, X., Martin, F., Forbush, K.A., Perlmutter, R.M. & Kearney, J.F. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int. Immunol. 9, 27–41 (1997).
MacLennan, I.C. Germinal centers. Annu. Rev. Immunol. 12, 117–139 (1994).
Muramatsu, M. et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553–563 (2000).
Lam, K.P. & Rajewsky, K. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J. Exp. Med. 190, 471–477 (1999).
Watanabe, N. et al. Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment. J. Exp. Med. 190, 461–469 (1999).
Kraus, M. et al. Interference with immunoglobulin (Ig)α immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igβ cytoplasmic tail. J. Exp. Med. 194, 455–469 (2001).
Caldwell, R.G., Wilson, J.B., Anderson, S.J. & Longnecker, R. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405–411 (1998).
Dykstra, M.L., Longnecker, R. & Pierce, S.K. Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity 14, 57–67 (2001).
Engels, N. et al. Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module. J. Exp. Med. 194, 255–264 (2001).
Miller, C.L. et al. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2, 155–166 (1995).
Fruehling, S. & Longnecker, R. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235, 241–251 (1997).
Donis-Hernandez, F.R., Parkhouse, R.M. & Santos-Argumedo, L. Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice. Eur. J. Immunol. 31, 1261–1267 (2001).
Fruehling, S., Swart, R., Dolwick, K.M., Kremmer, E. & Longnecker, R. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J. Virol. 72, 7796–7806 (1998).
Cebra, J.J., Logan, A.C. & Weinstein, P.D. The preference for switching to expression of the IgA isotype of antibody exhibited by B lymphocytes in Peyer's patches is likely due to intrinsic properties of their microenvironment. Immunol. Res. 10, 393–395 (1991).
Carroll, M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16, 545–568 (1998).
Goodnow, C.C. et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676–682 (1988).
Pelanda, R. et al. Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification. Immunity 7, 765–775 (1997).
Lam, K.P., Kuhn, R. & Rajewsky, K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073–1083 (1997).
Merchant, M., Caldwell, R.G. & Longnecker, R. The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo . J. Virol. 74, 9115–9124 (2000).
Herzenberg, L.A. B-1 cells: the lineage question revisited. Immunol. Rev. 175, 9–22 (2000).
Clarke, S.H. & Arnold, L.W. B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation. J. Exp. Med. 187, 1325–1334 (1998).
Hayakawa, K. et al. Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. J. Exp. Med. 197, 87–99 (2003).
Balazs, M., Martin, F., Zhou, T. & Kearney, J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17, 341–352 (2002).
Schneider, P. et al. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J. Exp. Med. 194, 1691–1697 (2001).
Girkontaite, I. et al. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat. Immunol. 2, 855–862 (2001).
Guinamard, R., Okigaki, M., Schlessinger, J. & Ravetch, J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1, 31–36 (2000).
Lu, T.T. & Cyster, J.G. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297, 409–412 (2002).
Saito, T. et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 18, 675–685 (2003).
Ikeda, A., Caldwell, R.G., Longnecker, R. & Ikeda, M. Itchy, a Nedd4 ubiquitin ligase, downregulates latent membrane protein 2A activity in B-cell signaling. J. Virol. 77, 5529–5534 (2003).
Portis, T. & Longnecker, R. Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development. J. Virol. 77, 105–114 (2003).
Sato, S., Steeber, D.A. & Tedder, T.F. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. USA 92, 11558–11562 (1995).
Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745 (2000).
Hoshino, K. et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749–3752 (1999).
Walport, M.J. Complement. First of two parts. N. Engl. J. Med. 344, 1058–1066 (2001).
Neutra, M.R., Mantis, N.J. & Kraehenbuhl, J.P. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2, 1004–1009 (2001).
Rescigno, M., Rotta, G., Valzasina, B. & Ricciardi-Castagnoli, P. Dendritic cells shuttle microbes across gut epithelial monolayers. Immunobiology 204, 572–581 (2001).
Koni, P.A. & Flavell, R.A. Lymph node germinal centers form in the absence of follicular dendritic cell networks. J. Exp. Med. 189, 855–864 (1999).
Lanning, D., Zhu, X., Zhai, S.K. & Knight, K.L. Development of the antibody repertoire in rabbit: gut-associated lymphoid tissue, microbes, and selection. Immunol. Rev. 175, 214–228 (2000).
Reynaud, C.A., Anquez, V., Grimal, H. & Weill, J.C. A hyperconversion mechanism generates the chicken light chain preimmune repertoire. Cell 48, 379–388 (1987).
Reynaud, C.A., Mackay, C.R., Muller, R.G. & Weill, J.C. Somatic generation of diversity in a mammalian primary lymphoid organ: the sheep ileal Peyer's patches. Cell 64, 995–1005 (1991).
Jenne, C.N., Kennedy, L.J., McCullagh, P. & Reynolds, J.D. A new model of sheep Ig diversification: shifting the emphasis toward combinatorial mechanisms and away from hypermutation. J. Immunol. 170, 3739–3750 (2003).
Weller, S. et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc. Natl. Acad. Sci. USA 98, 1166–1170 (2001).
Kueppers, R. & Rajewsky, K. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annu. Rev. Immunol. 16, 471–493 (1998).
Kanzler, H., Kuppers, R., Hansmann, M.L. & Rajewsky, K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184, 1495–1505 (1996).
Sonoda, E. et al. B cell development under the condition of allelic inclusion. Immunity 6, 225–233 (1997).
Sauer, B. Manipulation of transgenes by site-specific recombination: use of Cre recombinase. Methods Enzymol. 225, 890–900 (1993).
Schwenk, F., Baron, U. & Rajewsky, K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080–5081 (1995).
Wessels, M.R. et al. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 92, 11490–11494 (1995).
Pelanda, R., Schaal, S., Torres, R.M. & Rajewsky, K. A prematurely expressed Igκ transgene, but not VκJκ gene segment targeted into the Igκ locus, can rescue B cell development in λ5-deficient mice. Immunity 5, 229–239 (1996).
Birkenbach, M., Josefsen, K., Yalamanchili, R., Lenoir, G. & Kieff, E. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J. Virol. 67, 2209–2220 (1993).
Acknowledgements
We thank G. Esposito, ZY. Hao, A. Waisman, U. Zimber-Strobl and W. Hammerschmidt for discussions; T. Novobrantseva for sharing unpublished results and for critical reading of the manuscript; T. Schneider for providing IgHHEL IgLHEL mice; T.W. Behrens for B1-8hi;3-83κi mice; and S. Willms, A. Egert, A. Roth, C. Goettlinger, N. Barteneva, D. Ghitza and V. Dreier for technical assistance. Supported by the National Institutes of Health (CA098285-01A1 and CA92625; K.R.), the Volkswagen Foundation (K.R.) and the Human Frontier Science Program and the Cancer Research Institute (S.C.).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Casola, S., Otipoby, K., Alimzhanov, M. et al. B cell receptor signal strength determines B cell fate. Nat Immunol 5, 317–327 (2004). https://doi.org/10.1038/ni1036
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1036
This article is cited by
-
Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression
Drugs (2023)
-
Mucosal or systemic microbiota exposures shape the B cell repertoire
Nature (2020)
-
IgA and the intestinal microbiota: the importance of being specific
Mucosal Immunology (2020)
-
Tunable dynamics of B cell selection in gut germinal centres
Nature (2020)
-
BCR selection and affinity maturation in Peyer’s patch germinal centres
Nature (2020)